BXMPY (Beximco Pharmaceuticals) Inventories, Raw Materials & Components: $95.12 Mil (As of Dec. 2024)


What is Beximco Pharmaceuticals Inventories, Raw Materials & Components?

Beximco Pharmaceuticals BXMPY 97 Inventories, Raw Materials & Components is $95.12 Mil as of Dec. 2024. GuruFocus rates BXMPY with a GF Score™ of 97/100. The stock has 2 warning signs investors should review.

Beximco Pharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $95.12 Mil.

Beximco Pharmaceuticals's quarterly raw materials declined from Jun. 2024 ($71.87 Mil) to Sep. 2024 ($6.95 Mil) but then increased from Sep. 2024 ($6.95 Mil) to Dec. 2024 ($95.12 Mil).

Beximco Pharmaceuticals's annual raw materials increased from Jun. 2022 ($64.02 Mil) to Jun. 2023 ($68.86 Mil) and increased from Jun. 2023 ($68.86 Mil) to Jun. 2024 ($71.87 Mil).

Beximco Pharmaceuticals Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Beximco Pharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beximco Pharmaceuticals Inventories, Raw Materials & Components Chart

Beximco Pharmaceuticals Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.52 49.49 64.02 68.86 71.87

Beximco Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.30 8.38 71.87 6.95 95.12

Beximco Pharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $95.12 Mil mean?
Beximco Pharmaceuticals (BXMPY) has a Inventories, Raw Materials & Components of $95.12 Mil as of Dec. 2024. Raw materials are the components a company uses for its main products. View historical data on Beximco Pharmaceuticals and its competitors.
Is Beximco Pharmaceuticals' Inventories, Raw Materials & Components too high?
Beximco Pharmaceuticals' current Inventories, Raw Materials & Components is $95.12 Mil. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Inventories, Raw Materials & Components compare to ZTS and UTHR?
Beximco Pharmaceuticals' Inventories, Raw Materials & Components of $95.12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Beximco Pharmaceuticals and its competitors. Beximco Pharmaceuticals's current Inventories, Raw Materials & Components is $95.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Inventories, Raw Materials & Components of $95.12 Mil. The current Inventories, Raw Materials & Components is $95.12 Mil. Beximco Pharmaceuticals' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Inventories, Raw Materials & Components is $95.12 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beximco Pharmaceuticals Business Description

Address 19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.